SECURITIES AND EXCHANGE COMMISSION
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
September 27, 2018
Date of Report (date of earliest event reported)
(Exact Name of Registrant as Specified in its Charter)
(State or Other Jurisdiction
17571 Von Karman Ave.
(Address of Principal Executive Offices
Including Zip Code)
(Registrants Telephone Number,
Including Area Code)
(Former Name or Former Address if Changed
Since Last Report)
Page 1 of 2 pages
Item 7.01 Regulation FD Disclosure
On September 27, 2018, Biomerica, Inc. (the Company) will present an investor presentation to the investment community.
The investor presentation is being furnished pursuant to General Instruction B.2 of Form 8-K and is not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), nor is it subject to the liabilities of that section or deemed incorporated by reference in any filing by the Company under the Exchange Act unless specifically identified therein as being incorporated therein by reference.
Item 9.01 Financial Statements and Exhibits
99.1 Investor Presentation
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 27, 2018
/s/ Zackary S. Irani
Zackary S. Irani
Chief Executive Officer